Metformin versus Placebo in Obese Pregnant Women without Diabetes Mellitus
Author(s) -
Argyro Syngelaki,
K. H. Nicolaides,
Jyoti Balani,
Steve Hyer,
Ranjit Akolekar,
Reena Kotecha,
Alice Pastides,
Hassan Shehata
Publication year - 2016
Publication title -
new england journal of medicine
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1509819
Subject(s) - medicine , metformin , gestational diabetes , pregnancy , body mass index , obstetrics , placebo , gestation , diabetes mellitus , birth weight , preeclampsia , weight gain , endocrinology , body weight , alternative medicine , pathology , biology , genetics
Obesity is associated with an increased risk of adverse pregnancy outcomes. Lifestyle-intervention studies have not shown improved outcomes. Metformin improves insulin sensitivity and in pregnant patients with gestational diabetes it leads to less weight gain than occurs in those who do not take metformin.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom